An anti-HIV infection drug has “clear potential” to prevent people catching the virus, a Welsh Government-commissioned report has said. Pre-exposure prophylaxis (PrEP) is not currently available on the Welsh NHS. But a report by an independent HIV expert group said it was “highly effective” when used with ...

Patients receiving long-term tenofovir therapy for hepatitis B virus (HBV) infection have an increased risk for abnormalities in bone metabolism, such as low serum phosphate, according to a study published in the Annals of Hepatology.1 Tenofovir, a first-line antiviral agent for HBV, is generally well-tolerated, although ...

Inflammatory mechanisms of innate immunity known to be involved in neurodegeneration in HIV-associated neurocognitive disorders (HAND) can be modulated by agents approved in autoimmune neuroinflammation leading to reduced neurotoxicity. About 50% of HIV infected patients have neurocognitive disorders associated with the infection. Despite being on combined ...

Treatment Action Group (TAG) released a statement in strong opposition to the President’s 2018 budget blueprint. The blueprint threatens research essential to ending the epidemics of HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV) in the United States and globally by cutting funding and eliminating ...

Odessa in Ukraine has become the latest city to sign the Paris Declaration to end the AIDS epidemic in cities. Since the end of 2014, more than 200 cities around the world have signed the Paris Declaration and are addressing the significant disparities in access ...

Copenhagen and Stockholm, 20 March 2017 New data released today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis (TB) cases and deaths in the 53 countries of the ...

ECUO presents the first pilot database of ARV drugs purchased in Eastern Europe and Central Asia (EECA) for both state budget funds and funds of international organizations Earlier, ECUO team initiated the Regional Monitoring on Drug Supply Access (Regional Monitoring) which was conducted in 2016 involving ...

The findings advance progress toward HIV vaccine design DURHAM, N.C., March 15, 2017 – A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination. “A ...

SWAN, within the Regional Platform EECA, has developed a video and community guide  on the community’s engagement in Global Fund supported processes on the national level. “Engaging in Global Fund Process. A Community Perspective”  reflects the experiences of sex workers’ communities from 6 countries: Kyrgyzstan, Ukraine, ...

A regional program in Eastern Europe and Central Asia (EECA) will pilot an innovative city service model to combat HIV and TB, with a special focus on key affected populations (KAPs). The city service model was implemented in Western Europe, the U.S. and Canada as far ...

The 11th meeting of the WHO European Advisory Group on Tuberculosis Control (TAG-TB) took place on 13 and 14th February in Copenhagen, Denmark. The meeting was chaired by Professor Alberto Matteelli, and widely attended by WHO officers from countries, academia, civil society members and community ...

Partner Dialogue on Participation of Civil Society Organizations (CSO) in the TB-REP Project and Exchange of Operational Information was held in the capital of Denmark and attended by East Europe and Central Asia Union of People Living with HIV (ECUO) representatives. Meeting Summary - ECUO and Stop ...

Researchers have been successful in increasing HIV treatment success rates by almost 18 percent. Teams from the Universities of Aberdeen, Maastricht and the University and Academic Medical Centre in Amsterdam, developed a new programme designed to better assist patients treated for HIV in taking their ...

The Stop TB Partnership delivered the letter to WHO requesting inclusion of Mycobacterium tuberculosis in the WHO’s Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics. STOP TB PARTNERSHIP ANNOUNCEMENT Geneva, Switzerland – 6 March 2017 — We would like to ...

University of Alabama at Birmingham School of Nursing Professor David Vance, Ph.D., has received a two-year, $404,250 R21 grant from the National Institute of Nursing Research for his project “Individualized-Targeted Training in Older Adults with HAND” to develop cognitive training interventions to improve everyday functioning ...

Global TB community demands inclusion of Mycobacterium tuberculosis in the WHO’s Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics. Join the Stop TB Partnership in its appeal to the World Health Organization (WHO) to add TB to the Global ...

Transatlantic agreement will help to make better use of inspection capacity and reduce duplication Regulators in the European Union (EU) and the United States (US) have agreed to recognise inspections of manufacturing sites for human medicines conducted in their respective territories on both sides of the ...

In 2016, a regional action plan for Europe that aims to contribute to the implementation of the global viral hepatitis elimination strategy was developed by the WHO Regional Office for Europe. In an article published in Eurosurveillance, the authors take a closer look how Europe ...